CYP24A1 and hypercalcemia disease: In general, pathogenic CYP24A1 mutations are relatively rare but in view of the high prevalence of vitamin D supplementation during preconception and pregnancy, affected women are at particularly high risk of severe hypercalcemia and associated obstetrics complications.